Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
172M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
101M
-
Shares change
-
+1.36M
-
Total reported value, excl. options
-
$147M
-
Value change
-
+$1.18M
-
Number of buys
-
51
-
Number of sells
-
-23
-
Price
-
$1.45
Significant Holders of Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) as of Q4 2024
98 filings reported holding CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101M shares
of 172M outstanding shares and own 59.09% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (22.4M shares), Blackstone Inc. (10M shares), MPM BIOIMPACT LLC (8.57M shares), Enavate Sciences GP, LLC (7.79M shares), BlackRock, Inc. (6.89M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (5.99M shares), TANG CAPITAL MANAGEMENT LLC (5.9M shares), Rock Springs Capital Management LP (5.78M shares), VANGUARD GROUP INC (4.72M shares), and FMR LLC (4.14M shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.